Evogene Ltd.
corporate_fare Company Profile
Evogene Ltd. (NASDAQ:EVGN) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors EVGN SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Activist Investors Push for Board Overhaul at Evogene After Building 16.7% Stake
- Evogene Forms Joint Initiative with Tel Aviv University to Boost AI-Driven Drug Discovery
- Evogene Achieves Major AI Milestone with Google Cloud, Advancing Drug Discovery Platform
- Evogene Finalizes Highly Dilutive $2.9M ATM Offering Amidst Delisting and Going Concern Risks
- Evogene Establishes Highly Dilutive $2.9M ATM Offering Amidst Delisting Concerns
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for EVGN, detected from its recent SEC filings · latest filing 2026-06-11.
ATM Offering Finalized · Significant Potential Dilution
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
EVGN files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.